Subcutaneous Allergen Immunotherapy in Adults Allergic to House Dust Mites: A Phase 3 Randomized Controlled Trial. [PDF]
Bachert C +11 more
europepmc +1 more source
Development and validation of a Guinea pig model for concurrent allergic rhinitis and asthma using recombinant Der f 2. [PDF]
Xu F, Hu L, Wang J, Zhang L.
europepmc +1 more source
Effect of house dust mite sublingual immunotherapy in patients with adult atopic dermatitis with rhinitis. [PDF]
Mizuno M +7 more
europepmc +1 more source
Immunohistopathological Analysis of Spongiosis Formation in Atopic Dermatitis Compared with Other Skin Diseases. [PDF]
Tanei R, Hasegawa Y.
europepmc +1 more source
Exploring the indicative role of ACT score in improving lung function in asthmatic children undergoing dust mite immunotherapy. [PDF]
Zhang P +5 more
europepmc +1 more source
Efficacy and safety of a house dust mites allergoid in patients with allergic rhinitis-PROACAROS study: protocol for a randomized controlled trial. [PDF]
Buendía-Jiménez I +5 more
europepmc +1 more source
Predictive value of Der p 2-specific IgE for subcutaneous immunotherapy in children with allergic rhinitis. [PDF]
Wang J +6 more
europepmc +1 more source
Mechanism differences in the start time of sublingual immunotherapy in a mouse allergic airway inflammation model. [PDF]
Saito A +13 more
europepmc +1 more source
Inhalant Allergen Sensitization: Prevalence, Risk Factors, and Geographic Variation in the USA.
Kwong K, Chen Z, Scott L, Hilborne LH.
europepmc +1 more source
Carbamylated monomeric allergoids for sublingual immunotherapy in pediatric respiratory allergies. [PDF]
Kim CK, Compalati E, Callaway Z.
europepmc +1 more source

